Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study-Reference-Cited by-同舟云学术

Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study

Published:2024-05 Issue: Volume:40 Page:100886
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Acs Balazs,Hartman Johan,Sönmez Demet,Lindman Henrik,Johansson Anna L.V.^ORCID,Fredriksson Irma

Funder

Merck Sharp & Dohme Ltd

Publisher

Elsevier BV

Reference33 articles.

1. Molecular classification of breast cancer;Zhang;Arch Pathol Lab Med,2022

2. Pattern of metastatic spread in triple-negative breast cancer;Dent;Breast Cancer Res Treat,2009

3. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer;Li;Breast Cancer Res Treat,2017

4. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection;Lehmann;PLoS One,2016

5. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer;Burstein;Clin Cancer Res,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas;Scientific Reports;2024-08-20

2. Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer;JNCI: Journal of the National Cancer Institute;2024-07-31

3. Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?;The Lancet Regional Health - Europe;2024-05